Follow the SCL사이언스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, SCL사이언스 has published 56 insider filings. Market capitalisation: €66.3bn. The latest transaction was filed on 27 May 2026 (Purchase). Among the most active insiders: 대신신기술투자조합제15호. All data is openly available.
53
Insider Decl.
n/a
Thresholds
n/a
34 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Fundamental score
Ranked 26,887 of 29,062 companies
18.9
score / 100
Value
21
Quality
17
FCF yld-5.8%
Earn yld-4.9%
EV/EBITDA·
ROE-15%
Gross mgn19%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
SCL사이언스 es una empresa que opera en el sector sanitario y farmacéutico, cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el campo médico.